1-13 of 13
Benoit Tessoulin, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Absence of Influence of the Pre-Transplant Immune Status of Recipients on Survivals and Gvhd after Allogeneic Stem Cell Transplantation: A Retrospective Study of 195 Cases

Baptiste Le Calvez, Thierry Guillaume, MD PhD, Pierre Peterlin, MD, Alice Garnier, MD, Amandine Le Bourgeois, MD, Marie Audrain, MD PhD, Marion Eveillard, Thomas Dejoie, Béatrice Mahé, MD, Viviane Dubruille, Nicolas Blin, MD, Cyrille Touzeau, Thomas Gastinne, MD, Anne Lok, Benoit Tessoulin, MD PhD, Sophie Vantyghem, Steven Le Gouill, MD PhD, Philippe Moreau, MD, Marie C Bene, PharmSci, PhD, Patrice Chevalier, MD PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 2–3.
https://doi.org/10.1182/blood-2020-136743
Published: 2020
Journal Articles

Inhibition of ATR Overcomes Chemotherapy Resistance in p53 Deficient Myeloma Cells

Louise Bouard, MDin training, Benoit Tessoulin, MD PhD, Géraldine Descamps, PhD, Cyrille Touzeau, MD PhD, Philippe Moreau, MD, Martine Amiot, PhD, Catherine Pellat-Deceunynck, PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 3109.
https://doi.org/10.1182/blood-2019-122547
Published: 2019
Journal Articles

Ptcy + ATG Compared to Ptcy Alone As Gvhd Prophylaxis for Peripheral Blood Stem Cells Allotransplant Is Associated with Significant Lower Incidence of Acute Gvhd without Increasing Relapse or Death By Infection

Patrice Chevallier, MD, Pierre Peterlin, Alice Garnier, MD, Amandine Le Bourgeois, MD, Beatrice Mahe, MD, Viviane Dubruille, MD, Nicolas Blin, MD, Cyrille Touzeau, MD, Thomas Gastinne, MD, Anne Lok, MD, Benoit Tessoulin, MD PhD, Yannick Le Bris, PharmD, Marie C Bene, PharmSci, PhD, Steven Le Gouill, MD PhD, Philippe Moreau, MD, Thierry Guillaume, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 4528.
https://doi.org/10.1182/blood-2019-125787
Published: 2019
Journal Articles

Profound Lymphopenia at the Time of ATG Administration Is Not Predictive of Survivals after Allotransplant Using Purine Analogue/Busulfan-Based Conditioning Regimen

Maxime Jullien, MD, Thierry Guillaume, MD PhD, Pierre Peterlin, Alice Garnier, MD, Amandine Le Bourgeois, MD, Camille Debord, PharmD, Beatrice Mahe, MD, Viviane Dubruille, MD, Soraya Wuilleme, PharmD, PhD, Nicolas Blin, MD, Cyrille Touzeau, MD PhD, Thomas Gastinne, MD, Benoit Tessoulin, MD PhD, Yannick Le Bris, PharmD, Marion Eveillard, Alix Duquesne, Philippe Moreau, MD, Steven Le Gouill, Marie-Christine Bene, PharmSciD, PhD, Patrice Chevallier, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 1985.
https://doi.org/10.1182/blood-2019-122013
Published: 2019
Journal Articles

A New Cytokine-Based Stratification Is Highly Predictive of Survivals in AML Patients

Pierre Peterlin, Joelle Gaschet, PhD, Thierry Guillaume, MD PhD, Alice Garnier, MD, Marion Eveillard, Amandine Le Bourgeois, MD, Michel Cherel, MD PhD, Juliette Brouazin, Camille Debord, PharmD, Yannick Le Bris, PharmD, Olivier Theisen, MD, Beatrice Mahe, MD, Viviane Dubruille, MD, Soraya Wuilleme, PharmD, PhD, Catherine Godon, Cyrille Touzeau, MD, Thomas Gastinne, MD, Nicolas Blin, MD, Anne Lok, Benoit Tessoulin, MD PhD, Steven Le Gouill, Philippe Moreau, MD, Marie-Christine Béné, PharmSciD, PhD, Patrice Chevallier, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 1412.
https://doi.org/10.1182/blood-2019-125774
Published: 2019
Journal Articles

Poor Prognosis Associated with Gains of CCND1 in Mantle Cell Lymphoma Treated By First Line Immuno-Chemotherapy — a Study By the Lysa Group

Yannick LE Bris, MD PharmD, Olivier Theisen, MD, Anne Moreau, MD, Florence Magrangeas, PhD, Danielle Canioni, MD, Barbara Burroni, MD, Catherine Thieblemont, MD, Lucie Oberic, MD, Krimo Bouabdallah, MD, Emmanuel Gyan, MD PhD, David Chiron, PhD, Catherine Pellat-deceunynck, PhD, Benoit Tessoulin, MD, Catherine Godon, MD, Marie-Helene Delfau, MD, Mary Callanan, PhD, Stephane Minvielle, PhD, Marie C Bene, PharmSci, PhD, Olivier Hermine, MD PhD, Steven LE Gouill, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 4099.
https://doi.org/10.1182/blood-2018-99-113303
Published: 2018
Journal Articles

Respective Place of Venetoclax and MCL1 BH3 Mimetics in Multiple Myeloma Treatment

Patricia Gomez-Bougie, PhD, Sophie Maïga, Benoit Tessoulin, MD, Jessie Bourcier, MD, Antoine Bonnet, MD, Géraldine Descamps, PhD, Carolane Seiller, Cyrille Touzeau, MD PhD, Philippe Moreau, Catherine Pellat-Deceunynck, PhD, Martine Amiot, PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 953.
https://doi.org/10.1182/blood-2018-99-109987
Published: 2018
Journal Articles

Correlations between p16 Protein Expression and Genomic Profile in Mantle Cell Lymphoma and Impact on Survival, a Lyma-Genomic Project Conducted on Behalf of the Lysa Group

Yannick LE Bris, MDPharmD, Danielle Canioni, MD, Barbara Burroni, MD, Anne Moreau, MD, Benoit Tessoulin, MD, Florence Magrangeas, PhD, Marie-Helene Delfau, MD, Catherine Thieblemont, MD, Lucie Oberic, MD, Krimo Bouabdallah, MD, Emmanuel Gyan, MD PhD, David Chiron, PhD, Catherine Pellat-deceunynck, PhD, Mary Callanan, PhD, Stephane Minvielle, PhD, Marie C Bene, PharmSci, PhD, Olivier Hermine, MD PhD, Steven Le Gouill, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 2846.
https://doi.org/10.1182/blood-2018-99-113268
Published: 2018
Journal Articles

CSF1R and BTK Inhibitions As Novel Strategies to Disrupt the Dialogue between Mantle Cell Lymphoma and Macrophages

Antonin Papin, Benoit Tessoulin, MD, Céline Bellanger, Anne Moreau, MD, Yannick LE Bris, MDPharmD, Herve Maisonneuve, MD, Philippe Moreau, Cyrille Touzeau, MD PhD, Martine Amiot, PhD, Catherine Pellat-Deceunynck, PhD, Steven Le Gouill, MD PhD, David Chiron, PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 2855.
https://doi.org/10.1182/blood-2018-99-114504
Published: 2018
Journal Articles

The Use of a BH3 Mimetic Toolkit Reveals a Switch of Myeloma Patients Dependency from BCL2 at Diagnosis to MCL1 at Relapse

Antoine Bonnet, MD, Jessie Bourcier, MD, Patricia Gomez-Bougie, PhD, Sophie Maïga, Benoit Tessoulin, MD, Philippe Moreau, MDPhD, Steven Le Gouill, MDPhD, Catherine Pellat-Deceunynck, PhD, Cyrille Touzeau, MD PhD, Martine Amiot, PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 4383.
https://doi.org/10.1182/blood.V130.Suppl_1.4383.4383
Published: 2017
Journal Articles

Human Myeloma Cell Lines Mutation Landscape: Toward a Rationale Use of Cell Lines to Assess Drug Efficacy Prediction in Myeloma

Benoit Tessoulin, MD, Agnes Moreau-Aubry, PhD, Alban Gaignard, PhD, Martine Amiot, PhD, Catherine Pellat-Deceunynck, PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 1770.
https://doi.org/10.1182/blood.V130.Suppl_1.1770.1770
Published: 2017
Journal Articles

The Oncolytic Measles Virus Preferentially Infects p53 Abnormal Myeloma Cells

Anne Lok, MD, Geraldine Descamps, PhD, Benoit Tessoulin, MD, Philippe Moreau, Steven Le Gouill, MD PhD, Frederic Tangy, PhD, Martine Amiot, Catherine Pellat-Deceunynck, PhD
Journal: Blood
Blood (2016) 128 (22): 310.
https://doi.org/10.1182/blood.V128.22.310.310
Published: 2016
Journal Articles

Lymphoid-like Environment, Which Promotes Proliferation and Induces Resistance to BH3-Mimetics, Is Counteracted By Obinutuzumab in MCL: Biological Rationale for the Oasis Clinical Trial

David Chiron, PhD, Celine Bellanger, Antonin Papin, Benoit Tessoulin, MD, Christelle Dousset, Sophie Maiga, Anne Moreau, MD, Julie Esbelin, MD, Valerie Trichet, PhD, Selina Chen-Kiang, PhD, Philippe Moreau, Cyrille Touzeau, MD, Steven Le Gouill, MD PhD, Martine Amiot, Catherine Pellat-Deceunynck, PhD
Journal: Blood
Blood (2016) 128 (22): 1096.
https://doi.org/10.1182/blood.V128.22.1096.1096
Published: 2016